QA: Bioxytran INC in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001445815_2025_Bioxytran_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001445815, Bioxytran INC

  xvar xval
0 AssetsCurrent 5,154
1 IntangibleAssetsNetIncludingGoodwill 133,540
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 1,930,642
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,153,465
9 ResearchAndDevelopmentExpense 112,337
10 remainder_Expenses 887,506
11 remainder_Revenues 0
12 remainder_NetIncome -130,310
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 138,694
1 Liabilities 1,930,642
2 Expenses 2,153,308
3 Revenues 0
4 StockholdersEquity -1,791,948
5 NetIncome -2,283,618
6 ComprehensiveNetIncome -2,283,618
7 BaseVar 2,176,477
8 EconomicCapitalRatiobeforeLimitedLiability -5.98
9 EconomicCapitalRatio 0.0805

Edgar->Model Mapping

Feature Distribution

Change over Time